Symbol:
Dlx5
Name:
distal-less homeobox 5
RGD ID:
2506
Description:
Predicted to enable DNA-binding transcription activator activity, RNA polymerase II-specific; HMG box domain binding activity; and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Involved in cellular response to zinc ion starvation and positive regulation of osteoblast differentiation. Predicted to be located in chromatin; cytoplasm; and nucleus. Human ortholog(s) of this gene implicated in split hand-foot malformation 1 and split hand-foot malformation 1 with sensorineural hearing loss. Orthologous to human DLX5 (distal-less homeobox 5); INTERACTS WITH 1,2,4-trimethylbenzene; 17alpha-ethynylestradiol; 6-propyl-2-thiouracil.
Type:
protein-coding
RefSeq Status:
PROVISIONAL
Previously known as:
Distal-less homeobox; DLX-3; homeobox protein DLX-3; homeobox protein DLX-5; RDLX
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 4 35,965,579 - 35,969,973 (-) NCBI GRCr8 mRatBN7.2 4 34,999,139 - 35,003,504 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 4 34,999,139 - 35,003,407 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 4 39,958,038 - 39,962,304 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 4 35,884,208 - 35,888,474 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 4 34,304,193 - 34,308,455 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 4 32,387,741 - 32,392,085 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 4 32,387,741 - 32,392,007 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 4 32,255,323 - 32,259,589 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 4 31,778,500 - 31,782,767 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 4 31,897,039 - 31,901,307 (-) NCBI Celera 4 30,515,648 - 30,519,914 (-) NCBI Celera Cytogenetic Map 4 q21 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Dlx5 Rat 1,2,4-trimethylbenzene increases expression EXP 6480464 pseudocumene results in increased expression of DLX5 protein CTD PMID:17337753 Dlx5 Rat 1,2-dichloroethane increases expression ISO Dlx5 (Mus musculus) 6480464 ethylene dichloride results in increased expression of DLX5 mRNA CTD PMID:28189721 and PMID:28960355 Dlx5 Rat 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine increases expression ISO Dlx5 (Mus musculus) 6480464 1-Methyl-4-phenyl-1 more ... CTD PMID:29627306 Dlx5 Rat 17alpha-ethynylestradiol affects expression ISO Dlx5 (Mus musculus) 6480464 Ethinyl Estradiol affects the expression of DLX5 mRNA CTD PMID:17555576 Dlx5 Rat 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of DLX5 mRNA CTD PMID:12075121 Dlx5 Rat 17alpha-ethynylestradiol multiple interactions ISO Dlx5 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DLX5 mRNA CTD PMID:17942748 Dlx5 Rat 17alpha-ethynylestradiol increases expression ISO Dlx5 (Mus musculus) 6480464 Ethinyl Estradiol results in increased expression of DLX5 mRNA CTD PMID:17942748 Dlx5 Rat 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO DLX5 (Homo sapiens) 6480464 2 more ... CTD PMID:31326446 Dlx5 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Dlx5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of DLX5 mRNA CTD PMID:24058054 Dlx5 Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO DLX5 (Homo sapiens) 6480464 N-(2-(3H-indol-3-yl)ethyl)-9-isopropyl-2-(5-methyl-3-pyridyl)purin-6-amine inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of DLX5 mRNA] CTD PMID:30203000 Dlx5 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO DLX5 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin affects the expression of DLX5 mRNA CTD PMID:30203000 Dlx5 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Dlx5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of DLX5 mRNA CTD PMID:15034205 Dlx5 Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Dlx5 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DLX5 mRNA CTD PMID:17942748 Dlx5 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Dlx5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of DLX5 mRNA CTD PMID:16962184 more ... Dlx5 Rat 3,3',5,5'-tetrabromobisphenol A increases expression ISO DLX5 (Homo sapiens) 6480464 tetrabromobisphenol A results in increased expression of DLX5 mRNA CTD PMID:31326446 Dlx5 Rat 4,4'-sulfonyldiphenol decreases methylation ISO DLX5 (Homo sapiens) 6480464 bisphenol S results in decreased methylation of DLX5 gene CTD PMID:31601247 Dlx5 Rat 5-aza-2'-deoxycytidine decreases expression ISO Dlx5 (Mus musculus) 6480464 Decitabine results in decreased expression of DLX5 mRNA CTD PMID:27915011 Dlx5 Rat 5-azacytidine increases expression ISO Dlx5 (Mus musculus) 6480464 Azacitidine results in increased expression of DLX5 mRNA CTD PMID:17085970 Dlx5 Rat 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of DLX5 mRNA CTD PMID:24780913 and PMID:30047161 Dlx5 Rat acetohydrazide decreases expression ISO Dlx5 (Mus musculus) 6480464 acetylhydrazine results in decreased expression of DLX5 mRNA CTD PMID:15282401 Dlx5 Rat all-trans-retinoic acid decreases expression ISO Dlx5 (Mus musculus) 6480464 Tretinoin results in decreased expression of DLX5 protein CTD PMID:17551590 Dlx5 Rat all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of DLX5 mRNA CTD PMID:20488242 Dlx5 Rat alpha-Zearalanol multiple interactions EXP 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of DLX5 mRNA CTD PMID:35163327 Dlx5 Rat amitrole increases expression EXP 6480464 Amitrole results in increased expression of DLX5 mRNA CTD PMID:30047161 Dlx5 Rat ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of DLX5 mRNA CTD PMID:16483693 Dlx5 Rat antirheumatic drug increases expression ISO DLX5 (Homo sapiens) 6480464 Antirheumatic Agents results in increased expression of DLX5 mRNA CTD PMID:24449571 Dlx5 Rat benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of DLX5 mRNA CTD PMID:21839799 Dlx5 Rat benzo[a]pyrene affects methylation ISO DLX5 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of DLX5 promoter CTD PMID:27901495 Dlx5 Rat benzo[a]pyrene increases methylation ISO DLX5 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of DLX5 5' UTR CTD PMID:27901495 Dlx5 Rat benzo[a]pyrene increases expression ISO Dlx5 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of DLX5 mRNA CTD PMID:15034205 Dlx5 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of DLX5 mRNA CTD PMID:12075121 more ... Dlx5 Rat bisphenol A affects methylation ISO Dlx5 (Mus musculus) 6480464 bisphenol A affects the methylation of DLX5 promoter CTD PMID:27334623 Dlx5 Rat butanal increases expression ISO DLX5 (Homo sapiens) 6480464 butyraldehyde results in increased expression of DLX5 mRNA CTD PMID:26079696 Dlx5 Rat C60 fullerene increases expression EXP 6480464 fullerene C60 results in increased expression of DLX5 mRNA CTD PMID:19167457 Dlx5 Rat cadmium atom affects expression ISO DLX5 (Homo sapiens) 6480464 Cadmium affects the expression of DLX5 mRNA CTD PMID:31082282 Dlx5 Rat cannabidiol increases expression ISO DLX5 (Homo sapiens) 6480464 Cannabidiol results in increased expression of DLX5 protein CTD PMID:32656944 Dlx5 Rat carbamazepine affects expression ISO DLX5 (Homo sapiens) 6480464 Carbamazepine affects the expression of DLX5 mRNA CTD PMID:25979313 Dlx5 Rat carbonyl sulfide increases expression EXP 6480464 carbonyl sulfide results in increased expression of DLX5 mRNA CTD PMID:19395590 Dlx5 Rat CGP 52608 multiple interactions ISO DLX5 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to DLX5 gene] CTD PMID:28238834 Dlx5 Rat clofibrate decreases expression ISO Dlx5 (Mus musculus) 6480464 Clofibrate results in decreased expression of DLX5 mRNA CTD PMID:17585979 Dlx5 Rat Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of DLX5 mRNA CTD PMID:26577399 Dlx5 Rat cyproconazole decreases expression ISO Dlx5 (Mus musculus) 6480464 cyproconazole results in decreased expression of DLX5 mRNA CTD PMID:22045034 Dlx5 Rat DDT increases expression ISO DLX5 (Homo sapiens) 6480464 DDT results in increased expression of DLX5 mRNA CTD PMID:25014179 Dlx5 Rat decabromodiphenyl ether increases expression ISO DLX5 (Homo sapiens) 6480464 decabromobiphenyl ether results in increased expression of DLX5 mRNA CTD PMID:31326446 Dlx5 Rat dexamethasone decreases expression ISO DLX5 (Homo sapiens) 6480464 Dexamethasone results in decreased expression of DLX5 mRNA CTD PMID:25047013 Dlx5 Rat dorsomorphin multiple interactions ISO DLX5 (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Dlx5 Rat fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of DLX5 mRNA CTD PMID:30307764 Dlx5 Rat flusilazole increases expression EXP 6480464 flusilazole results in increased expression of DLX5 mRNA CTD PMID:28263823 Dlx5 Rat fonofos increases methylation ISO DLX5 (Homo sapiens) 6480464 Fonofos results in increased methylation of DLX5 promoter CTD PMID:22847954 Dlx5 Rat genistein decreases expression EXP 6480464 Genistein results in decreased expression of DLX5 mRNA CTD PMID:12075121 Dlx5 Rat gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of DLX5 mRNA CTD PMID:33387578 Dlx5 Rat hexaconazole decreases expression ISO Dlx5 (Mus musculus) 6480464 hexaconazole results in decreased expression of DLX5 mRNA CTD PMID:22045034 Dlx5 Rat ketamine decreases expression EXP 6480464 Ketamine results in decreased expression of DLX5 mRNA CTD PMID:20080153 Dlx5 Rat mercury dibromide increases expression ISO DLX5 (Homo sapiens) 6480464 mercuric bromide results in increased expression of DLX5 mRNA CTD PMID:26272509 Dlx5 Rat mercury dibromide multiple interactions ISO DLX5 (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX5 mRNA CTD PMID:27188386 Dlx5 Rat methimazole increases expression EXP 6480464 Methimazole results in increased expression of DLX5 mRNA CTD PMID:30047161 Dlx5 Rat methylmercury chloride increases expression ISO DLX5 (Homo sapiens) 6480464 methylmercuric chloride results in increased expression of DLX5 mRNA CTD PMID:23179753 more ... Dlx5 Rat monosodium L-glutamate increases expression EXP 6480464 Sodium Glutamate results in increased expression of DLX5 mRNA CTD PMID:20928830 Dlx5 Rat morphine increases expression ISO Dlx5 (Mus musculus) 6480464 Morphine results in increased expression of DLX5 mRNA CTD PMID:21178816 Dlx5 Rat naphthalenes increases expression EXP 6480464 Naphthalenes results in increased expression of DLX5 protein CTD PMID:17337753 Dlx5 Rat ochratoxin A decreases expression ISO Dlx5 (Mus musculus) 6480464 ochratoxin A results in decreased expression of DLX5 mRNA CTD PMID:20036863 Dlx5 Rat oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of DLX5 mRNA CTD PMID:25729387 Dlx5 Rat oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of DLX5 mRNA CTD PMID:25729387 Dlx5 Rat p-chloromercuribenzoic acid increases expression ISO DLX5 (Homo sapiens) 6480464 p-Chloromercuribenzoic Acid results in increased expression of DLX5 mRNA CTD PMID:26272509 Dlx5 Rat p-chloromercuribenzoic acid multiple interactions ISO DLX5 (Homo sapiens) 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX5 mRNA CTD PMID:27188386 Dlx5 Rat parathion increases methylation ISO DLX5 (Homo sapiens) 6480464 Parathion results in increased methylation of DLX5 promoter CTD PMID:22847954 Dlx5 Rat perfluorooctane-1-sulfonic acid affects expression ISO DLX5 (Homo sapiens) 6480464 perfluorooctane sulfonic acid affects the expression of DLX5 mRNA CTD PMID:30738844 Dlx5 Rat perfluorooctanoic acid multiple interactions EXP 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of DLX5 mRNA CTD PMID:35163327 Dlx5 Rat progesterone decreases expression ISO Dlx5 (Mus musculus) 6480464 Progesterone results in decreased expression of DLX5 mRNA CTD PMID:22238285 Dlx5 Rat SB 431542 multiple interactions ISO DLX5 (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Dlx5 Rat sodium arsenite increases expression ISO DLX5 (Homo sapiens) 6480464 sodium arsenite results in increased expression of DLX5 mRNA CTD PMID:29301061 and PMID:34032870 Dlx5 Rat sodium arsenite decreases expression ISO Dlx5 (Mus musculus) 6480464 sodium arsenite results in decreased expression of DLX5 mRNA CTD PMID:37682722 Dlx5 Rat sulfadimethoxine increases expression EXP 6480464 Sulfadimethoxine results in increased expression of DLX5 mRNA CTD PMID:30047161 Dlx5 Rat tamoxifen affects expression ISO Dlx5 (Mus musculus) 6480464 Tamoxifen affects the expression of DLX5 mRNA CTD PMID:17555576 Dlx5 Rat terbufos increases methylation ISO DLX5 (Homo sapiens) 6480464 terbufos results in increased methylation of DLX5 promoter CTD PMID:22847954 Dlx5 Rat Tetrachlorobisphenol A increases expression ISO DLX5 (Homo sapiens) 6480464 tetrachlorodian results in increased expression of DLX5 mRNA CTD PMID:31326446 Dlx5 Rat tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of DLX5 mRNA CTD PMID:16239168 Dlx5 Rat thapsigargin decreases expression ISO DLX5 (Homo sapiens) 6480464 Thapsigargin results in decreased expression of DLX5 mRNA CTD PMID:22378314 Dlx5 Rat titanium dioxide decreases methylation ISO Dlx5 (Mus musculus) 6480464 titanium dioxide results in decreased methylation of DLX5 gene CTD PMID:35295148 Dlx5 Rat titanium dioxide increases methylation ISO Dlx5 (Mus musculus) 6480464 titanium dioxide results in increased methylation of DLX5 gene CTD PMID:35295148 Dlx5 Rat topotecan increases expression EXP 6480464 Topotecan results in increased expression of DLX5 mRNA CTD PMID:25729387 Dlx5 Rat topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of DLX5 mRNA CTD PMID:25729387 Dlx5 Rat trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of DLX5 mRNA CTD PMID:33387578 Dlx5 Rat trichostatin A increases expression ISO DLX5 (Homo sapiens) 6480464 trichostatin A results in increased expression of DLX5 mRNA CTD PMID:24935251 Dlx5 Rat tunicamycin decreases expression ISO DLX5 (Homo sapiens) 6480464 Tunicamycin results in decreased expression of DLX5 mRNA CTD PMID:22378314 and PMID:29453283 Dlx5 Rat valproic acid decreases expression ISO Dlx5 (Mus musculus) 6480464 Valproic Acid results in decreased expression of DLX5 mRNA CTD PMID:22045034 Dlx5 Rat valproic acid multiple interactions ISO DLX5 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX5 mRNA CTD PMID:27188386 Dlx5 Rat valproic acid increases expression ISO DLX5 (Homo sapiens) 6480464 Valproic Acid results in increased expression of DLX5 mRNA CTD PMID:23179753 more ... Dlx5 Rat zinc atom decreases expression EXP 6480464 Zinc deficiency results in decreased expression of DLX5 mRNA CTD PMID:21893222 Dlx5 Rat zinc(0) decreases expression EXP 6480464 Zinc deficiency results in decreased expression of DLX5 mRNA CTD PMID:21893222
1,2,4-trimethylbenzene (EXP) 1,2-dichloroethane (ISO) 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (ISO) 17alpha-ethynylestradiol (EXP,ISO) 2,2',4,4'-Tetrabromodiphenyl ether (ISO) 2,3,7,8-tetrachlorodibenzodioxine (ISO) 3,3',5,5'-tetrabromobisphenol A (ISO) 4,4'-sulfonyldiphenol (ISO) 5-aza-2'-deoxycytidine (ISO) 5-azacytidine (ISO) 6-propyl-2-thiouracil (EXP) acetohydrazide (ISO) all-trans-retinoic acid (EXP,ISO) alpha-Zearalanol (EXP) amitrole (EXP) ammonium chloride (EXP) antirheumatic drug (ISO) benzo[a]pyrene (EXP,ISO) bisphenol A (EXP,ISO) butanal (ISO) C60 fullerene (EXP) cadmium atom (ISO) cannabidiol (ISO) carbamazepine (ISO) carbonyl sulfide (EXP) CGP 52608 (ISO) clofibrate (ISO) Cuprizon (EXP) cyproconazole (ISO) DDT (ISO) decabromodiphenyl ether (ISO) dexamethasone (ISO) dorsomorphin (ISO) fenvalerate (EXP) flusilazole (EXP) fonofos (ISO) genistein (EXP) gentamycin (EXP) hexaconazole (ISO) ketamine (EXP) mercury dibromide (ISO) methimazole (EXP) methylmercury chloride (ISO) monosodium L-glutamate (EXP) morphine (ISO) naphthalenes (EXP) ochratoxin A (ISO) oxaliplatin (EXP) p-chloromercuribenzoic acid (ISO) parathion (ISO) perfluorooctane-1-sulfonic acid (ISO) perfluorooctanoic acid (EXP) progesterone (ISO) SB 431542 (ISO) sodium arsenite (ISO) sulfadimethoxine (EXP) tamoxifen (ISO) terbufos (ISO) Tetrachlorobisphenol A (ISO) tetrachloromethane (EXP) thapsigargin (ISO) titanium dioxide (ISO) topotecan (EXP) trichloroethene (EXP) trichostatin A (ISO) tunicamycin (ISO) valproic acid (ISO) zinc atom (EXP) zinc(0) (EXP)
Biological Process
anatomical structure formation involved in morphogenesis (IEA,ISO) axon guidance (IEA,ISO) axonogenesis (IEA,ISO) BMP signaling pathway (IEA,ISO) bone morphogenesis (IEA,ISO) cell differentiation (IBA) cell population proliferation (IEA,ISO,ISS) cellular response to zinc ion starvation (IEP) ear development (IEA,ISO) embryonic limb morphogenesis (IEA,ISO) embryonic skeletal system development (IBA) endochondral ossification (IEA,ISO,ISS) epithelial cell differentiation (IEA,ISO) face morphogenesis (IEA,ISO) head development (IEA,ISO) inner ear morphogenesis (IEA,ISO) interneuron axon guidance (IEA,ISO) olfactory bulb interneuron differentiation (IEA,ISO) olfactory pit development (IEA,ISO) ossification (IEA) osteoblast differentiation (IEA,ISO,ISS) positive regulation of canonical Wnt signaling pathway (IEA,ISO) positive regulation of DNA-templated transcription (IEA,ISO,ISS) positive regulation of epithelial cell proliferation (IEA,ISO) positive regulation of gene expression (IEA,ISO) positive regulation of osteoblast differentiation (IMP) positive regulation of transcription by RNA polymerase II (IEA,ISO) regulation of DNA-templated transcription (IEA,ISO) regulation of transcription by RNA polymerase II (IBA) roof of mouth development (IEA,ISO)
Molecular Function
DNA binding (IEA,ISO) DNA-binding transcription activator activity, RNA polymerase II-specific (IEA,ISO) DNA-binding transcription factor activity (TAS) DNA-binding transcription factor activity, RNA polymerase II-specific (IBA,IEA) HMG box domain binding (IEA,ISO) protein binding (ISO) RNA polymerase II cis-regulatory region sequence-specific DNA binding (IBA,IEA,ISO) sequence-specific double-stranded DNA binding (IEA,ISO) transcription cis-regulatory region binding (IEA,ISO,ISS)
1.
Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.
Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
2.
Rat ISS GO annotations from GOA human gene data--August 2006
GOA data from the GO Consortium
3.
Zinc deficiency decreases osteoblasts and osteoclasts associated with the reduced expression of Runx2 and RANK.
Hie M, etal., Bone. 2011 Dec;49(6):1152-9. doi: 10.1016/j.bone.2011.08.019. Epub 2011 Aug 26.
4.
BMP-2-induced Runx2 expression is mediated by Dlx5, and TGF-beta 1 opposes the BMP-2-induced osteoblast differentiation by suppression of Dlx5 expression.
Lee MH, etal., J Biol Chem 2003 Sep 5;278(36):34387-94. Epub 2003 Jun 18.
5.
Rat ISS GO annotations from MGI mouse gene data--August 2006
MGD data from the GO Consortium
6.
Electronic Transfer of LocusLink and RefSeq Data
NCBI rat LocusLink and RefSeq merged data July 26, 2002
7.
OMIM Disease Annotation Pipeline
OMIM Disease Annotation Pipeline
8.
GOA pipeline
RGD automated data pipeline
9.
ClinVar Automated Import and Annotation Pipeline
RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
10.
Data Import for Chemical-Gene Interactions
RGD automated import pipeline for gene-chemical interactions
11.
Molecular cloning and evolutional analysis of a mammalian homologue of the Distal-less 3 (Dlx-3) homeobox gene.
Shirasawa T, etal., FEBS Lett 1994 Sep 12;351(3):380-4.
12.
Tentative Sequence Identification Numbers
Tentative Sequence Data IDs. TIGR Gene Index, Rat Data
13.
rDlx, a novel distal-less-like homeoprotein is expressed in developing cartilages and discrete neuronal tissues.
Zhao GQ, etal., Dev Biol 1994 Jul;164(1):37-51.
Dlx5 (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 4 35,965,579 - 35,969,973 (-) NCBI GRCr8 mRatBN7.2 4 34,999,139 - 35,003,504 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 4 34,999,139 - 35,003,407 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 4 39,958,038 - 39,962,304 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 4 35,884,208 - 35,888,474 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 4 34,304,193 - 34,308,455 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 4 32,387,741 - 32,392,085 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 4 32,387,741 - 32,392,007 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 4 32,255,323 - 32,259,589 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 4 31,778,500 - 31,782,767 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 4 31,897,039 - 31,901,307 (-) NCBI Celera 4 30,515,648 - 30,519,914 (-) NCBI Celera Cytogenetic Map 4 q21 NCBI
DLX5 (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 7 97,020,396 - 97,024,831 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 7 97,020,396 - 97,024,950 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 7 96,649,708 - 96,654,143 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 7 96,487,638 - 96,492,079 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 7 96,294,358 - 96,298,794 NCBI Celera 7 91,343,634 - 91,348,072 (-) NCBI Celera Cytogenetic Map 7 q21.3 NCBI HuRef 7 91,251,295 - 91,255,732 (-) NCBI HuRef CHM1_1 7 96,579,739 - 96,584,181 (-) NCBI CHM1_1 T2T-CHM13v2.0 7 98,250,072 - 98,254,502 (-) NCBI T2T-CHM13v2.0 CRA_TCAGchr7v2 7 95,972,198 - 95,976,639 (-) NCBI
Dlx5 (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 6 6,877,801 - 6,882,068 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 6 6,877,805 - 6,882,085 (-) Ensembl GRCm39 Ensembl GRCm38 6 6,877,801 - 6,882,068 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 6 6,877,805 - 6,882,085 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 6 6,827,805 - 6,832,068 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 6 6,827,805 - 6,832,068 (-) NCBI MGSCv36 mm8 Celera 6 7,023,868 - 7,028,132 (-) NCBI Celera Cytogenetic Map 6 A1 NCBI cM Map 6 2.83 NCBI
Dlx5 (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955432 13,429,415 - 13,434,258 (-) Ensembl ChiLan1.0 ChiLan1.0 NW_004955432 13,429,832 - 13,434,160 (-) NCBI ChiLan1.0 ChiLan1.0
DLX5 (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 6 114,856,668 - 114,863,007 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 7 163,121,305 - 163,127,639 (-) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 7 88,972,066 - 88,977,588 (-) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 7 102,556,636 - 102,561,186 (-) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 7 102,555,267 - 102,561,186 (-) Ensembl panpan1.1 panPan2
DLX5 (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 14 22,080,351 - 22,085,188 (-) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 14 22,080,699 - 22,084,867 (-) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 14 21,648,083 - 21,652,478 (-) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 14 21,897,429 - 21,901,826 (-) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 14 21,897,417 - 21,902,078 (-) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 14 22,044,142 - 22,048,532 (-) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 14 21,779,484 - 21,783,873 (-) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 14 22,043,227 - 22,047,620 (-) NCBI UU_Cfam_GSD_1.0
Dlx5 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024405118 35,346,260 - 35,401,337 (-) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936585 3,461,944 - 3,466,641 (+) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936585 3,462,063 - 3,466,641 (+) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
DLX5 (Sus scrofa - pig)
LOC103226510 (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 21 52,032,933 - 52,092,791 (+) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 21 52,036,401 - 52,040,903 (+) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666042 52,268,203 - 52,315,364 (-) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Dlx5 (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 56 Count of miRNA genes: 48 Interacting mature miRNAs: 56 Transcripts: ENSRNOT00000014946 Prediction methods: Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
2302371 Stl22 Serum triglyceride level QTL 22 5.15 blood triglyceride amount (VT:0002644) serum triglyceride level (CMO:0000360) 4 5218294 57114705 Rat 2303585 Bw86 Body weight QTL 86 4 body mass (VT:0001259) body weight (CMO:0000012) 4 14678065 59678065 Rat 8552906 Pigfal3 Plasma insulin-like growth factor 1 level QTL 3 blood insulin-like growth factor amount (VT:0010479) plasma insulin-like growth factor 1 level (CMO:0001299) 4 10084089 55084089 Rat 10755501 Bp390 Blood pressure QTL 390 2.5 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 4 26775591 168368347 Rat 8655949 Rf62 Renal function QTL 62 22 blood urea nitrogen amount (VT:0005265) plasma urea nitrogen level (CMO:0000586) 4 34430119 44463908 Rat 6478766 Anxrr47 Anxiety related response QTL 47 0.09637 locomotor behavior trait (VT:0001392) number of entries into a discrete space in an experimental apparatus (CMO:0000960) 4 10084089 55084089 Rat 8552782 Vie1 Viral induced encephalitis QTL 1 26.4 brain integrity trait (VT:0010579) encephalitis incidence/prevalence measurement (CMO:0002361) 4 34430484 82490359 Rat 70222 Eae2 Experimental allergic encephalomyelitis QTL 2 4.3 nervous system integrity trait (VT:0010566) experimental autoimmune encephalomyelitis incidence/prevalence measurement (CMO:0001046) 4 21333343 39505420 Rat 631642 Stl2 Serum triglyceride level QTL 2 3.3 blood triglyceride amount (VT:0002644) serum triglyceride level (CMO:0000360) 4 5219178 56647776 Rat 6478769 Anxrr48 Anxiety related response QTL 48 0.02514 locomotor behavior trait (VT:0001392) amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958) 4 10084089 55084089 Rat 631261 Tcas3 Tongue tumor susceptibility QTL 3 6.88 tongue integrity trait (VT:0010553) number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950) 4 10814170 91360527 Rat 634323 Hc2 Hypercalciuria QTL 2 2.15 urine calcium amount (VT:0002985) urine calcium excretion rate (CMO:0000763) 4 210796 45210796 Rat 2313401 Anxrr27 Anxiety related response QTL 27 aggression-related behavior trait (VT:0015014) tameness/aggressiveness composite score (CMO:0002136) 4 17933508 62933508 Rat 631209 Bw2 Body weight QTL2 4.2 retroperitoneal fat pad mass (VT:0010430) retroperitoneal fat pad weight to body weight ratio (CMO:0000635) 4 9940885 44463908 Rat 6909128 Pancm4 Pancreatic morphology QTL 4 11.35 pancreas mass (VT:0010144) pancreas wet weight (CMO:0000626) 4 26907285 75585128 Rat 8694374 Bw155 Body weight QTL 155 3.39 0.001 body lean mass (VT:0010483) lean tissue morphological measurement (CMO:0002184) 4 10084089 55084089 Rat 2303168 Bp330 Blood pressure QTL 330 4.25 0.017 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 4 5214602 146446691 Rat 8552801 Bw143 Body weight QTL 143 7.3 body mass (VT:0001259) change in body weight to body weight ratio (CMO:0002216) 4 34430484 82490359 Rat 61412 Pia2 Pristane induced arthritis QTL 2 3.9 joint integrity trait (VT:0010548) post-insult time to onset of experimental arthritis (CMO:0001450) 4 21333343 62278020 Rat 6478724 Anxrr35 Anxiety related response QTL 35 0.00449 defecation behavior trait (VT:0010462) defecation measurement (CMO:0000997) 4 10084089 55084089 Rat 8655906 Rf60 Renal function QTL 60 3.8 blood creatinine amount (VT:0005328) creatinine clearance (CMO:0000765) 4 29494195 81006281 Rat 61415 Eae11 Experimental allergic encephalomyelitis QTL 11 2.9 nervous system integrity trait (VT:0010566) post-insult time to onset of experimental autoimmune encephalomyelitis (CMO:0001422) 4 1 39505420 Rat 619616 Bp79 Blood pressure QTL 79 0.0292 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 4 5214602 78882945 Rat 7387227 Uae40 Urinary albumin excretion QTL 40 2.9 0.0052 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 4 17946999 62946999 Rat 6909122 Insul22 Insulin level QTL 22 4.63 blood insulin amount (VT:0001560) plasma insulin level (CMO:0000342) 4 26907285 75585128 Rat 8552809 Vie5 Viral induced encephalitis QTL 5 25.3 brain integrity trait (VT:0010579) encephalitis incidence/prevalence measurement (CMO:0002361) 4 34430484 82490359 Rat 1358203 Stl19 Serum triglyceride level QTL 19 2.8 0.002 blood triglyceride amount (VT:0002644) serum triglyceride level (CMO:0000360) 4 5218294 65958103 Rat 9590304 Scort17 Serum corticosterone level QTL 17 4.96 0.001 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 4 10084089 55084089 Rat 12798520 Anxrr55 Anxiety related response QTL 55 4.45 0.01 locomotor behavior trait (VT:0001392) number of rearing movements with lid-pushing in an experimental apparatus (CMO:0002715) 4 32583980 114627242 Rat 11530004 Niddm71 Non-insulin dependent diabetes mellitus QTL 71 0.001 blood glucose amount (VT:0000188) blood glucose level area under curve (AUC) (CMO:0000350) 4 32584199 52754138 Rat 2316958 Gluco58 Glucose level QTL 58 10 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 4 11320076 180699135 Rat 1354665 Stl10 Serum triglyceride level QTL 10 3.57 blood triglyceride amount (VT:0002644) serum triglyceride level (CMO:0000360) 4 21333343 44463908 Rat 1300141 Bp178 Blood pressure QTL 178 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 4 10024901 39524530 Rat
AA998469
Rat Assembly Chr Position (strand) Source JBrowse GRCr8 4 35,965,762 - 35,966,628 (+) Marker Load Pipeline Rnor_6.0 4 32,387,925 - 32,388,790 NCBI Rnor6.0 Rnor_5.0 4 32,255,507 - 32,256,372 UniSTS Rnor5.0 RGSC_v3.4 4 31,778,684 - 31,779,550 UniSTS RGSC3.4 Celera 4 30,515,832 - 30,516,697 UniSTS RH 3.4 Map 4 811.83 UniSTS Cytogenetic Map 4 q13 UniSTS
AI385752
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 4 34,999,397 - 34,999,499 (+) MAPPER mRatBN7.2 Rnor_6.0 4 32,388,000 - 32,388,101 NCBI Rnor6.0 Rnor_5.0 4 32,255,582 - 32,255,683 UniSTS Rnor5.0 RGSC_v3.4 4 31,778,759 - 31,778,860 UniSTS RGSC3.4 Celera 4 30,515,907 - 30,516,008 UniSTS Cytogenetic Map 4 q13 UniSTS
MARC_9717-9718:996688547:1
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 4 35,002,916 - 35,003,225 (+) MAPPER mRatBN7.2 Rnor_6.0 4 32,391,517 - 32,391,825 NCBI Rnor6.0 Rnor_5.0 4 32,259,099 - 32,259,407 UniSTS Rnor5.0 RGSC_v3.4 4 31,782,277 - 31,782,585 UniSTS RGSC3.4 Celera 4 30,519,424 - 30,519,732 UniSTS Cytogenetic Map 4 q13 UniSTS
Dlx5
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 4 34,999,262 - 34,999,813 (+) MAPPER mRatBN7.2 Rnor_6.0 4 32,387,865 - 32,388,415 NCBI Rnor6.0 Rnor_5.0 4 32,255,447 - 32,255,997 UniSTS Rnor5.0 RGSC_v3.4 4 31,778,624 - 31,779,174 UniSTS RGSC3.4 Celera 4 30,515,772 - 30,516,322 UniSTS Cytogenetic Map 4 q13 UniSTS
DLX5_2316
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 4 34,999,093 - 34,999,786 (+) MAPPER mRatBN7.2 Rnor_6.0 4 32,387,696 - 32,388,388 NCBI Rnor6.0 Rnor_5.0 4 32,255,278 - 32,255,970 UniSTS Rnor5.0 RGSC_v3.4 4 31,778,455 - 31,779,147 UniSTS RGSC3.4 Celera 4 30,515,603 - 30,516,295 UniSTS Cytogenetic Map 4 q13 UniSTS
Dlx5
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 4 34,999,182 - 34,999,598 (+) MAPPER mRatBN7.2 Rnor_6.0 4 32,387,785 - 32,388,200 NCBI Rnor6.0 Rnor_5.0 4 32,255,367 - 32,255,782 UniSTS Rnor5.0 RGSC_v3.4 4 31,778,544 - 31,778,959 UniSTS RGSC3.4 Celera 4 30,515,692 - 30,516,107 UniSTS Cytogenetic Map 4 q13 UniSTS
Dlx5
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 4 35,003,163 - 35,003,228 (+) MAPPER mRatBN7.2 Rnor_6.0 4 32,391,764 - 32,391,828 NCBI Rnor6.0 Rnor_5.0 4 32,259,346 - 32,259,410 UniSTS Rnor5.0 RGSC_v3.4 4 31,782,524 - 31,782,588 UniSTS RGSC3.4 Celera 4 30,519,671 - 30,519,735 UniSTS Cytogenetic Map 4 q13 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
7
3
46
106
36
33
11
10
11
6
120
73
89
26
48
22
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000014946 ⟹ ENSRNOP00000014946
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 4 34,999,139 - 35,003,407 (-) Ensembl Rnor_6.0 Ensembl 4 32,387,741 - 32,392,007 (-) Ensembl
RefSeq Acc Id:
NM_012943 ⟹ NP_037075
RefSeq Status:
PROVISIONAL
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 4 35,965,579 - 35,969,845 (-) NCBI mRatBN7.2 4 34,999,139 - 35,003,407 (-) NCBI Rnor_6.0 4 32,387,741 - 32,392,007 (-) NCBI Rnor_5.0 4 32,255,323 - 32,259,589 (-) NCBI RGSC_v3.4 4 31,778,500 - 31,782,767 (-) RGD Celera 4 30,515,648 - 30,519,914 (-) RGD
Sequence:
GACAGAGCCTCCACGACTCCCAGCCTCCTCCTCCCCGCCGCCGCCGCCACCGCCGCCGCCTCCTCTTCCTCCTCCTCCTCCCTCGCTCCCACAGCCATGTCTGCTTAGACCAGAGCAGCTCCACAGCC AATTCTGGCAGCAGCGGCCGCCTCAATAGGACAGCCACCGCCCGGGAGCTATGACAGGAGTGTTTGACAGAAGAGTCCCAAGCATCCGATCCGGCGACTTCCAAGCTCCGTTCCCGACGTCCGCCGCC ATGCACCACCCGTCTCAGGAATCGCCAACTTTGCCGGAGTCCTCGGCCACCGATTCTGACTACTACAGTCCCGCGGGGGCCGCCCCTCATGGCTACTGCTCTCCTACCTCTGCTTCTTACCGCAAAGC GCTCAACCCATACCAGTACCAGTATCACAGCGTGAACGGCTCCGCAGCCGGCTACCCGGCCAAGGCTTATGCGGACTACGGCTACGCCAGCCCCTACCACCAGTACGGAGGCGCCTACAACCGAGTCC CGAGTGCCACCAGCCAGCCAGAGAAAGAAGTGGCCGAGCCAGAGGTGAGGATGGTGAATGGTAAACCAAAGAAAGTTCGTAAACCCAGGACTATTTATTCCAGCTTTCAGCTGGCCGCTTTACAGAGA AGGTTTCAGAAGACTCAGTACCTCGCCCTGCCAGAACGCGCGGAGTTGGCCGCCTCTCTAGGACTGACGCAAACACAGGTGAAAATCTGGTTTCAGAACAAAAGATCCAAGATCAAGAAGATCATGAA AAACGGGGAGATGCCCCCGGAGCACAGTCCCAGCTCCAGCGACCCTATGGCGTGTAACTCGCCACAGTCACCAGCGGTGTGGGAGCCCCAGGGCTCATCCCGCTCTCTCAGCCACCACCCTCATGCCC ACCCTACGACCTCCAACCAGTCCCCCGCGTCCAGCTACCTGGAGAACTCGGCTTCCTGGTACCCAAGTGCAGCCAGCTCAATCAATTCCCACCTGCCACCGCCTGGCTCCCTGCAGCACCCGCTGGCA CTGGCCTCCGGGACGCTTTATTAGATGGGCTACTCTCTCTTGCTCAGTTTTGGGACTACAGTGTTTTCCTGTTTTAGAAATCAGAAAGAAAGGAATTCATACGGGGATGTTTGAACAATGGAAACAAA GATTCATGTGTAAAGCTTTTTTTTTGCATGTAAGTTATTGCATTTCAAAGGACCCCGCCCCTTTTTTTACGAAAAGAACCCTTTTTTGCGCAACTGTGGACACTATCAATGGTGCCTTGAAATCTATG ACCTCAACTTTTCAAAAAGACTTTTTTCAATGTTATTTTAACCGTGTAAATAAGTGTAGATAGAGGAATTAAACTGTATATTCTGGATAAATAAAATTATTTCGACCATG
hide sequence
RefSeq Acc Id:
XM_017592486 ⟹ XP_017447975
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 4 35,966,225 - 35,969,973 (-) NCBI mRatBN7.2 4 34,999,675 - 35,003,504 (-) NCBI Rnor_6.0 4 32,389,485 - 32,392,085 (-) NCBI
Sequence:
ACCCCGCTGTGCGTAAGCGCGCAATTAAGGATTTAACCAAGGCTGTGCTGCGCCTCAGCCAACAGTCAGCCTGCGGGAGACAGAGCCTCCACGACTCCCAGCCTCCTCCTCCCCGCCGCCGCCGCCAC CGCCGCCGCCTCCTCTTCCTCCTCCTCCTCCCTCGCTCCCACAGCCATGTCTGCTTAGACCAGAGCAGCTCCACAGCCAATTCTGGCAGCAGCGGCCGCCTCAATAGGACAGCCACCGCCCGGGAGCT ATGACAGGAGTGTTTGACAGAAGAGTCCCAAGCATCCGATCCGGCGACTTCCAAGCTCCGTTCCCGACGTCCGCCGCCATGCACCACCCGTCTCAGGAATCGCCAACTTTGCCGGAGTCCTCGGCCAC CGATTCTGACTACTACAGTCCCGCGGGGGCCGCCCCTCATGGCTACTGCTCTCCTACCTCTGCTTCTTACCGCAAAGCGCTCAACCCATACCAGTACCAGTATCACAGCGTGAACGGCTCCGCAGCCG GCTACCCGGCCAAGGCTTATGCGGACTACGGCTACGCCAGCCCCTACCACCAGTACGGAGGCGCCTACAACCGAGTCCCGAGTGCCACCAGCCAGCCAGCTTTCAGCTGGCCGCTTTACAGAGAAGGT TTCAGAAGACTCAGTACCTCGCCCTGCCAGAACGCGCGGAGTTGGCCGCCTCTCTAG
hide sequence
RefSeq Acc Id:
NP_037075 ⟸ NM_012943
- UniProtKB:
A0A0G2JSK6 (UniProtKB/TrEMBL), A6IDV1 (UniProtKB/TrEMBL)
- Sequence:
MTGVFDRRVPSIRSGDFQAPFPTSAAMHHPSQESPTLPESSATDSDYYSPAGAAPHGYCSPTSASYRKALNPYQYQYHSVNGSAAGYPAKAYADYGYASPYHQYGGAYNRVPSATSQPEKEVAEPEVR MVNGKPKKVRKPRTIYSSFQLAALQRRFQKTQYLALPERAELAASLGLTQTQVKIWFQNKRSKIKKIMKNGEMPPEHSPSSSDPMACNSPQSPAVWEPQGSSRSLSHHPHAHPTTSNQSPASSYLENS ASWYPSAASSINSHLPPPGSLQHPLALASGTLY
hide sequence
RefSeq Acc Id:
XP_017447975 ⟸ XM_017592486
- Peptide Label:
isoform X1
- Sequence:
MTGVFDRRVPSIRSGDFQAPFPTSAAMHHPSQESPTLPESSATDSDYYSPAGAAPHGYCSPTSA SYRKALNPYQYQYHSVNGSAAGYPAKAYADYGYASPYHQYGGAYNRVPSATSQPAFSWPLYREGFRRLSTSPCQNARSWPPL
hide sequence
Ensembl Acc Id:
ENSRNOP00000014946 ⟸ ENSRNOT00000014946
RGD ID: 13692867
Promoter ID: EPDNEW_R3391
Type: single initiation site
Name: Dlx5_1
Description: distal-less homeobox 5
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Experiment Methods: Single-end sequencing.
Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 4 32,392,025 - 32,392,085 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2002-06-10
Dlx5
Distal-less homeobox
Symbol and Name status set to approved
70586
APPROVED
Note Type
Note
Reference
gene_expression
expressed specifically in osteogenic cells
1298882
gene_expression
expressed in developing skeletal and neuronal tissues
1298881
gene_expression
expressed in fibroblasts
1298881
gene_process
important mediator of BMP-2-induced Runx2 expression
1298882
gene_process
induces BMP-2 mediated osetoeblast differentiation and blocks TGFB1-mediated inhibition of osteoblast differentiation
1298882
gene_transcript
induced by bone morphogenic protein (BMP) 2 and 4 signaling
1298882
gene_transcript
suppressed by TGFB1
1298882